Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience
Acta Gastro Enterologica Belgica · 2021
DOI: 10.51821/84.1.349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Gastro Enterologica Belgica, 2021. Verfasst von L Wauters und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium and Translational Research Center for Gastrointestinal Disorders (TARGID), …. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Fibrinolytic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Background
Impact of antithrombotics on the fecal immunochemical test (FIT) for colorectal cancer (CRC) screening remains unclear.
Methods
Patients undergoing colonoscopy for positive FIT in 2015 were assessed at 3 Belgian centers. Significant findings were advanced polyps (AP) (sessile serrated, tubular or villous adenomas >1cm or high-grade dysplasia) and CRC. False positive FIT and detection of AP/CRC with antithrombotics were calculated.
Results
510 patients (64% male, median (IQR) age 63.2 (60.2-66.4) years) were included. Colorectal pathology in 371/510 (73%) was associated with male gender (70% vs. 48% ; p= .0001) and family history (16% vs. 8% ; p= .02). Antithrombotics in 125/510 (25%) were associated with male gender (78% vs. 59% ; p= .0001), older age (65.2 (62.2-70.3) vs. 62.3 (58.7-66.3) years ; p= .0001) and GI-symptoms (18% vs. 11% ; p= .04). False positive FIT (25% vs. 28% ; p= .52) and detection of AP (42% vs. 36% ; p= .27) or CRC (6% vs. 5% ; p= .69) were similar in patients with vs. no antithrombotics. Use of antithrombotics did not predict a higher chance of colorectal pathology after adjusting for confounders.
Conclusion
Although antithrombotics were prescribed more frequently in male and older patients, detection of AP/CRC was similar. Despite increased GI symptoms, false positive FIT was similar with antithrombotics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, UZ Leuven, Leuven, Belgium and Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
- Department of Gastroenterology, UMC Utrecht, Utrecht, The Netherlands.
- Department of Gastroenterology, OLV Hospitals Aalst/Asse/Ninove, Aalst, Belgium.
- Department of Gastroenterology, UZ Gent, Gent, Belgium.
Zitieren
APA
Wauters, L., Van der Voort, V. R. H., Dobbels, P., Hendrickx, K., Casneuf, V., & Vandervoort, J. (2021). Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience. Acta Gastro Enterologica Belgica. https://doi.org/10.51821/84.1.349
Vancouver
Wauters L, Van der Voort VRH, Dobbels P, Hendrickx K, Casneuf V, Vandervoort J. Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience. Acta Gastro Enterologica Belgica. 2021. doi:10.51821/84.1.349
BibTeX
@article{Wauters2021,
author = {Wauters, L and Van der Voort, V R H and Dobbels, P and Hendrickx, K and Casneuf, V and Vandervoort, J},
title = {Impact of antithrombotics on the fecal immunochemical test for colorectal cancer screening : a multi-center Belgian experience},
journal = {Acta Gastro Enterologica Belgica},
year = {2021},
doi = {10.51821/84.1.349}
}
EUVIMED